Like ALDI, who shattered its own record of new stores opening in a single year. Or Trader Joe’s, who is planning to open 20 ...

Discover Five Below, Inc.'s growth through store expansion despite e-commerce competition and trade pressures. Click for more ...

National clothing chain to close long-standing Wichita location © 2025 American City Business Journals. All rights reserved.

In this light, Five Below’s counter-recession strategy is pretty unusual. While it may be unusual, it is not reckless. Its expansion plans are backed by solid financial performance. Five Below ...

SM Prime Holdings—the real estate developer controlled by the billionaire Sy family’s SM Investments—will spend 500 billion pesos ($9 billion) over five ... s expansion plans and the stock ...

They’re quite hostile to the expansion of satellite internet ... journalist Karen Hao writes about the rise of OpenAI and the impacts of AI around the world. Below is an extract from the book on the ...

Standard Capital Markets Ltd., a non-banking financial company (NBFC) listed on the BSE and classified as a penny stock, has raised ₹121 crore via allotment of 12,100 non-convertible debentures ...

The discount retailer said sales will come in stronger than previously expected for the quarter ending Saturday.

PHILADELPHIA, PA, May 02, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ ... risks related to the Company's strategy and expansion plans, risks related to our ability to attract, retain ...

The Outlets of Des Moines is getting a new edition: Five Below is set to open in fall 2025. The store is known for its trendy selection of affordable clothes, room décor, accessories, sports gear ...

Roche and the pharmaceutical industry as a whole are grappling with the effects of President Donald Trump’s tariffs on imports to the U.S. Drugmaker Novartis’ also plans to spend $23 billion ...

Besides, Novartis, Johnson & Johnson plans to spend $55 billion ... Story continues below photo gallery. The company said the multipronged expansion would ensure that "all key Novartis medicines ...